Literature DB >> 27616617

Categorization and repair of recurrent and acquired tracheoesophageal fistulae occurring after esophageal atresia repair.

C Jason Smithers1, Thomas E Hamilton2, Michael A Manfredi2, Lawrence Rhein2, Peter Ngo2, Dorothy Gallagher2, John E Foker2, Russell W Jennings2.   

Abstract

PURPOSE: Recurrent trachea-esophageal fistula (recTEF) is a frequent (5%-10%) complication of congenital TEF (conTEF) and esophageal atresia (EA) repair. In addition, postoperative acquired TEF (acqTEF) can occur in addition to or even in the absence of prior conTEF in the setting of esophageal anastomotic complications. Reliable repair often proves difficult by endoluminal or standard surgical techniques. We present the results of an approach that reliably identifies the TEF and facilitates airway closure as well as repair of associated tracheal and esophageal problems.
METHODS: Retrospective review of 66 consecutive patients 2009-2016 (55 referrals and 11 local) who underwent repair via reoperative thoracotomy or cervicotomy for recTEF and acqTEF (IRB P00004344). Our surgical approach used complete separation of the airway and esophagus, which reliably revealed the TEF (without need for cannulation) and freed the tissues for primary closure of the trachea and frequently resection of the tracheal diverticulum. For associated esophageal strictures, stricturoplasty or resection was performed. Separation of the suture lines by rotational pexy of the both esophagus and the trachea, and/or tissue interposition were used to further inhibit re-recurrence. For associated severe tracheomalacia, posterior tracheopexy to the anterior spinal ligament was utilized.
RESULTS: The TEFs were recurrent (77%), acquired from esophageal leaks (26%), in addition to persistent or missed H-type (6%). Seven patients in this series had multiple TEFs of more than one category. Of the acqTEF cases, 6 were esophagobronchial, 10 esophagopulmonic, 2 esophagotracheal (initial pure EA cases), and 2 from a gastric conduit to the trachea. Upon referral, 18 patients had failed endoluminal treatments; and open operations for recTEF had failed in 18 patients. Significant pulmonary symptoms were present in all. During repairs, 58% were found to have a large tracheal diverticulum, and 51% had posterior tracheopexy for significant tracheomalacia. For larger esophageal defects, 32% were treated by stricturoplasty and 37% by segmental resection. Rotational pexy of the trachea and/or esophagus was utilized in 62% of cases to achieve optimal suture line separation. Review with a mean follow-up of 35months identified no recurrences, and resolution of pulmonary symptoms in all. Stricture treatment required postoperative dilations in 30, and esophageal replacement in 6 for long strictures. There was one death.
CONCLUSION: This retrospective review of 66 patients with postoperative recurrent and acquired TEF following esophageal atresia repair is the largest such series to date and provides a new categorization for postoperative TEF that helps clarify the diagnostic and therapeutic challenges for management.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Esophageal atresia; Recurrent tracheoesophageal fistula; Reoperative esophageal surgery; Revisional esophageal surgery; Tracheoesophageal fistula; Tracheomalacia

Mesh:

Year:  2016        PMID: 27616617     DOI: 10.1016/j.jpedsurg.2016.08.012

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  9 in total

1.  Thoracoscopic recurrent tracheo-oesophageal fistula repair with mini endostapler: promising solution.

Authors:  Indalecio Cano Novillo; Belén Aneiros Castro; Araceli García Vázquez; Mónica De Miguel Moya
Journal:  BMJ Case Rep       Date:  2019-05-30

2.  Risk Factors and Reasons for Treatment Abandonment for Patients With Esophageal Atresia: A Study From a Tertiary Care Hospital in Beijing, China.

Authors:  Shen Yang; Junmin Liao; Siqi Li; Kaiyun Hua; Peize Wang; Yanan Zhang; Yong Zhao; Yichao Gu; Shuangshuang Li; Jinshi Huang
Journal:  Front Pediatr       Date:  2021-04-27       Impact factor: 3.418

Review 3.  Respiratory Morbidity in Children with Repaired Congenital Esophageal Atresia with or without Tracheoesophageal Fistula.

Authors:  Maria Francesca Patria; Stefano Ghislanzoni; Francesco Macchini; Mara Lelii; Alessandro Mori; Ernesto Leva; Nicola Principi; Susanna Esposito
Journal:  Int J Environ Res Public Health       Date:  2017-09-27       Impact factor: 3.390

4.  Acquired Tracheoesophageal Fistula After Esophageal Atresia Repair

Authors:  Özlem Boybeyi Türer; Feridun Cahit Tanyel; Tutku Soyer
Journal:  Balkan Med J       Date:  2019-11-19       Impact factor: 2.021

5.  Comment on “Acquired Tracheoesophageal Fistula after Esophageal Atresia Repair”

Authors:  Vedat Akçaer
Journal:  Balkan Med J       Date:  2020-07-03       Impact factor: 2.021

6.  Diagnostic Value of Prenatal Ultrasound Parameters and Esophageal Signs in Pouch and Lower Thoracic Segment in Fetuses with Esophageal Atresia.

Authors:  Wenjun Feng
Journal:  Comput Math Methods Med       Date:  2021-12-22       Impact factor: 2.238

7.  Anaesthetic considerations for slide tracheoplasty for the management of recurrent tracheo-oesophageal fistula.

Authors:  Kedar Bangal; Kirubanand Senniappan; Shreedhar S Joshi; Keshava Murthy
Journal:  Indian J Anaesth       Date:  2021-10-29

8.  Indocyanine green fluorescence imaging localization-assisted thoracoscopy revision surgery after repair of esophageal atresia.

Authors:  Yanan Zhang; Murong Wang; Shuangshuang Li; Junmin Liao; Kaiyun Hua; Shen Yang; Jinshi Huang
Journal:  BMC Gastroenterol       Date:  2022-08-05       Impact factor: 2.847

9.  Posterior Tracheopexy for Severe Tracheomalacia Associated with Esophageal Atresia (EA): Primary Treatment at the Time of Initial EA Repair versus Secondary Treatment.

Authors:  Hester F Shieh; C Jason Smithers; Thomas E Hamilton; David Zurakowski; Gary A Visner; Michael A Manfredi; Christopher W Baird; Russell W Jennings
Journal:  Front Surg       Date:  2018-01-15
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.